Symbols / PULM Stock $1.27 +1.60% Pulmatrix, Inc.
PULM (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
Ratings
Current target
$1.27
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-08-15 | reit | HC Wainwright & Co. | Buy → Buy | $10 |
| 2023-05-15 | reit | HC Wainwright & Co. | Buy → Buy | $10 |
| 2023-02-07 | reit | HC Wainwright & Co. | — → Buy | $10 |
| 2022-03-30 | main | HC Wainwright & Co. | — → Buy | $10 |
- Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger - PR Newswire ue, 21 Apr 2026 07
- Number of shareholders of Pulmatrix, Inc. – NASDAQ:PULM - TradingView Sun, 10 May 2026 10
- PULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire Mon, 13 Apr 2026 07
- Pulmatrix Raises $1M in Preferred Stock Financing - The Globe and Mail Wed, 22 Apr 2026 07
- What Just Happened to Pulmatrix (PULM) Stock - Kavout Fri, 27 Mar 2026 01
- Market Movers | Winners: GMGI, TPET, BATL | Losers: AARD, ALUR, PULM - Trefis ue, 03 Mar 2026 08
- Is Pulmatrix (PULM) Stock Good for Beginners | Price at $1.26, Down 4.55% - Earnings Breakout - Cổng thông tin điện tử tỉnh Lào Cai Wed, 08 Apr 2026 07
- Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead - Stocktwits Mon, 02 Mar 2026 08
- Pulmatrix Raises $1M in Preferred Stock Financing - TipRanks ue, 21 Apr 2026 07
- CSRC delays leave Pulmatrix merger dead, company hunts new deal - Stock Titan Mon, 02 Mar 2026 08
- Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results - PR Newswire hu, 26 Feb 2026 08
- Pulmatrix Announces Closing Of Preferred Stock Transaction As Part Of Planned Merger - TradingView ue, 21 Apr 2026 07
- Eos-backed investor takes 9.99% Pulmatrix (PULM) stake ahead merger - Stock Titan Wed, 22 Apr 2026 07
- Pulmatrix (PULM) Stock: Why Working Capital (Trades Higher) 2026-04-20 - Fibonacci Analysis - Cổng thông tin điện tử tỉnh Lào Cai Mon, 20 Apr 2026 15
- Pulmatrix closes $1M Series B preferred private placement tied to planned merger - TradingView ue, 21 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
-100.00%
|
7.81
+6.96%
|
7.30
+20.21%
|
6.07
|
| Operating Revenue |
|
0.00
-100.00%
|
7.81
+6.96%
|
7.30
+20.21%
|
6.07
|
| Operating Expense |
|
5.17
-65.43%
|
14.95
-32.16%
|
22.04
-11.91%
|
25.02
|
| Research And Development |
|
0.04
-99.47%
|
7.17
-53.82%
|
15.52
-14.92%
|
18.24
|
| Selling General And Administration |
|
5.13
-34.09%
|
7.79
+19.40%
|
6.52
-3.81%
|
6.78
|
| General And Administrative Expense |
|
5.13
-34.09%
|
7.79
+19.40%
|
6.52
-3.81%
|
6.78
|
| Other Gand A |
|
5.13
-34.09%
|
7.79
+19.40%
|
6.52
-3.81%
|
6.78
|
| Total Expenses |
|
5.17
-65.43%
|
14.95
-32.16%
|
22.04
-11.91%
|
25.02
|
| Operating Income |
|
-5.17
+27.66%
|
-7.14
+51.53%
|
-14.74
+22.20%
|
-18.95
|
| Total Operating Income As Reported |
|
-5.17
+47.06%
|
-9.76
+33.77%
|
-14.74
+22.20%
|
-18.95
|
| EBITDA |
|
-5.17
+22.97%
|
-6.71
+49.42%
|
-13.27
+23.77%
|
-17.40
|
| Normalized EBITDA |
|
-5.24
-30.09%
|
-4.03
+69.66%
|
-13.27
+23.77%
|
-17.40
|
| Reconciled Depreciation |
|
0.00
-100.00%
|
0.43
-70.51%
|
1.48
-4.53%
|
1.54
|
| EBIT |
|
-5.17
+27.66%
|
-7.14
+51.53%
|
-14.74
+22.20%
|
-18.95
|
| Total Unusual Items |
|
0.07
+102.50%
|
-2.69
|
0.00
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
0.07
+102.50%
|
-2.69
|
0.00
|
0.00
|
| Special Income Charges |
|
0.00
+100.00%
|
-2.62
|
0.00
|
0.00
|
| Impairment Of Capital Assets |
|
—
|
—
|
—
|
0.00
|
| Net Income |
|
-5.16
+46.00%
|
-9.56
+32.31%
|
-14.12
+25.03%
|
-18.84
|
| Pretax Income |
|
-5.16
+46.00%
|
-9.56
+32.31%
|
-14.12
+25.03%
|
-18.84
|
| Net Non Operating Interest Income Expense |
|
0.14
-69.16%
|
0.47
-46.14%
|
0.87
+180.58%
|
0.31
|
| Net Interest Income |
|
0.14
-69.16%
|
0.47
-46.14%
|
0.87
+180.58%
|
0.31
|
| Interest Income Non Operating |
|
0.14
-69.16%
|
0.47
-46.14%
|
0.87
+180.58%
|
0.31
|
| Interest Income |
|
0.14
-69.16%
|
0.47
-46.14%
|
0.87
+180.58%
|
0.31
|
| Other Income Expense |
|
-0.14
+95.24%
|
-2.88
-1061.69%
|
-0.25
-25.25%
|
-0.20
|
| Other Non Operating Income Expenses |
|
-0.20
-4.08%
|
-0.20
+20.97%
|
-0.25
-25.25%
|
-0.20
|
| Gain On Sale Of Security |
|
0.07
+200.00%
|
-0.07
|
—
|
—
|
| Gain On Sale Of Business |
|
0.00
+100.00%
|
-2.62
|
0.00
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-5.16
+46.00%
|
-9.56
+32.31%
|
-14.12
+25.03%
|
-18.84
|
| Net Income From Continuing Operation Net Minority Interest |
|
-5.16
+46.00%
|
-9.56
+32.31%
|
-14.12
+25.03%
|
-18.84
|
| Net Income From Continuing And Discontinued Operation |
|
-5.16
+46.00%
|
-9.56
+32.31%
|
-14.12
+25.03%
|
-18.84
|
| Net Income Continuous Operations |
|
-5.16
+46.00%
|
-9.56
+32.31%
|
-14.12
+25.03%
|
-18.84
|
| Normalized Income |
|
-5.23
+23.93%
|
-6.87
+51.32%
|
-14.12
+25.03%
|
-18.84
|
| Net Income Common Stockholders |
|
-5.16
+46.00%
|
-9.56
+32.31%
|
-14.12
+25.03%
|
-18.84
|
| Diluted EPS |
|
-1.41
+46.18%
|
-2.62
+32.30%
|
-3.87
+29.12%
|
-5.46
|
| Basic EPS |
|
-1.41
+46.18%
|
-2.62
+32.30%
|
-3.87
+29.12%
|
-5.46
|
| Basic Average Shares |
|
3.65
+0.00%
|
3.65
+0.01%
|
3.65
+5.92%
|
3.45
|
| Diluted Average Shares |
|
3.65
+0.00%
|
3.65
+0.01%
|
3.65
+5.92%
|
3.45
|
| Diluted NI Availto Com Stockholders |
|
-5.16
+46.00%
|
-9.56
+32.31%
|
-14.12
+25.03%
|
-18.84
|
| Preferred Stock Dividends |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
4.14
-58.37%
|
9.94
-70.72%
|
33.96
-17.08%
|
40.95
|
| Current Assets |
|
4.13
-58.38%
|
9.92
-52.41%
|
20.84
-45.36%
|
38.15
|
| Cash Cash Equivalents And Short Term Investments |
|
4.09
-57.06%
|
9.52
-50.34%
|
19.17
-46.19%
|
35.63
|
| Cash And Cash Equivalents |
|
4.09
-57.06%
|
9.52
-50.34%
|
19.17
-46.19%
|
35.63
|
| Receivables |
|
—
|
0.00
-100.00%
|
0.93
-28.51%
|
1.30
|
| Accounts Receivable |
|
—
|
0.00
-100.00%
|
0.93
-28.51%
|
1.30
|
| Prepaid Assets |
|
0.01
-96.80%
|
0.22
-40.81%
|
0.37
-58.98%
|
0.90
|
| Restricted Cash |
|
—
|
—
|
0.00
-100.00%
|
0.15
|
| Other Current Assets |
|
0.03
-81.11%
|
0.18
-51.61%
|
0.37
+124.10%
|
0.17
|
| Total Non Current Assets |
|
0.01
-56.52%
|
0.02
-99.82%
|
13.12
+367.39%
|
2.81
|
| Net PPE |
|
—
|
0.00
-100.00%
|
11.47
+1113.44%
|
0.94
|
| Gross PPE |
|
—
|
0.00
-100.00%
|
13.20
+257.51%
|
3.69
|
| Accumulated Depreciation |
|
—
|
0.00
+100.00%
|
-1.74
+36.83%
|
-2.75
|
| Properties |
|
—
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
—
|
0.00
-100.00%
|
0.64
+29.67%
|
0.49
|
| Construction In Progress |
|
—
|
0.00
-100.00%
|
0.60
|
0.00
|
| Other Properties |
|
—
|
—
|
11.96
+371.62%
|
2.54
|
| Leases |
|
—
|
0.00
|
0.00
-100.00%
|
0.66
|
| Goodwill And Other Intangible Assets |
|
—
|
—
|
—
|
—
|
| Goodwill |
|
—
|
—
|
—
|
—
|
| Other Non Current Assets |
|
0.01
-56.52%
|
0.02
-98.60%
|
1.65
-11.45%
|
1.86
|
| Total Liabilities Net Minority Interest |
|
0.33
-66.97%
|
1.00
-93.76%
|
15.96
+62.16%
|
9.84
|
| Current Liabilities |
|
0.33
-64.59%
|
0.93
-76.23%
|
3.91
-22.16%
|
5.02
|
| Payables And Accrued Expenses |
|
0.32
-63.29%
|
0.86
-68.95%
|
2.76
-1.07%
|
2.79
|
| Payables |
|
0.27
-66.38%
|
0.81
-57.75%
|
1.92
+61.20%
|
1.19
|
| Accounts Payable |
|
0.27
-66.38%
|
0.81
-57.75%
|
1.92
+61.20%
|
1.19
|
| Current Accrued Expenses |
|
0.04
-12.24%
|
0.05
-94.22%
|
0.85
-47.17%
|
1.60
|
| Current Debt And Capital Lease Obligation |
|
—
|
—
|
0.43
-49.94%
|
0.86
|
| Current Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
0.43
-49.94%
|
0.86
|
| Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
0.62
-53.85%
|
1.34
|
| Current Deferred Revenue |
|
—
|
0.00
-100.00%
|
0.62
-53.85%
|
1.34
|
| Other Current Liabilities |
|
0.01
-80.28%
|
0.07
-28.28%
|
0.10
+200.00%
|
0.03
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
0.07
-99.44%
|
12.05
+149.98%
|
4.82
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
8.33
|
0.00
|
| Long Term Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
8.33
|
0.00
|
| Non Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
3.73
-22.71%
|
4.82
|
| Non Current Deferred Revenue |
|
—
|
0.00
-100.00%
|
3.73
-22.71%
|
4.82
|
| Stockholders Equity |
|
3.81
-57.42%
|
8.95
-50.28%
|
18.00
-42.16%
|
31.11
|
| Common Stock Equity |
|
3.81
-57.42%
|
8.95
-50.28%
|
18.00
-42.16%
|
31.11
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
3.65
+0.00%
|
3.65
+0.00%
|
3.65
+0.36%
|
3.64
|
| Ordinary Shares Number |
|
3.65
+0.00%
|
3.65
+0.00%
|
3.65
+0.36%
|
3.64
|
| Additional Paid In Capital |
|
306.13
+0.01%
|
306.10
+0.17%
|
305.59
+0.33%
|
304.58
|
| Retained Earnings |
|
-302.32
-1.74%
|
-297.16
-3.32%
|
-287.60
-5.16%
|
-273.48
|
| Total Equity Gross Minority Interest |
|
3.81
-57.42%
|
8.95
-50.28%
|
18.00
-42.16%
|
31.11
|
| Total Capitalization |
|
3.81
-57.42%
|
8.95
-50.28%
|
18.00
-42.16%
|
31.11
|
| Working Capital |
|
3.80
-57.74%
|
8.99
-46.91%
|
16.93
-48.88%
|
33.12
|
| Invested Capital |
|
3.81
-57.42%
|
8.95
-50.28%
|
18.00
-42.16%
|
31.11
|
| Total Debt |
|
—
|
0.00
-100.00%
|
8.76
+921.70%
|
0.86
|
| Capital Lease Obligations |
|
—
|
0.00
-100.00%
|
8.76
+921.70%
|
0.86
|
| Net Tangible Assets |
|
3.81
-57.42%
|
8.95
-50.28%
|
18.00
-42.16%
|
31.11
|
| Tangible Book Value |
|
3.81
-57.42%
|
8.95
-50.28%
|
18.00
-42.16%
|
31.11
|
| Derivative Product Liabilities |
|
0.00
-100.00%
|
0.07
|
0.00
|
—
|
| Preferred Stock Equity |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-5.43
+49.30%
|
-10.72
+32.96%
|
-15.98
+17.42%
|
-19.36
|
| Cash Flow From Continuing Operating Activities |
|
-5.43
+49.30%
|
-10.72
+32.96%
|
-15.98
+17.42%
|
-19.36
|
| Net Income From Continuing Operations |
|
-5.16
+46.00%
|
-9.56
+32.31%
|
-14.12
+25.03%
|
-18.84
|
| Depreciation Amortization Depletion |
|
0.00
-100.00%
|
0.43
-70.51%
|
1.48
-4.53%
|
1.54
|
| Depreciation |
|
0.00
-100.00%
|
0.43
-70.51%
|
1.48
-4.53%
|
1.54
|
| Depreciation And Amortization |
|
0.00
-100.00%
|
0.43
-70.51%
|
1.48
-4.53%
|
1.54
|
| Stock Based Compensation |
|
0.03
-95.11%
|
0.51
-46.44%
|
0.95
-14.36%
|
1.11
|
| Asset Impairment Charge |
|
—
|
—
|
—
|
0.00
|
| Operating Gains Losses |
|
-0.07
-102.50%
|
2.69
+33462.50%
|
0.01
|
—
|
| Gain Loss On Investment Securities |
|
-0.07
-200.00%
|
0.07
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
—
|
—
|
0.01
|
0.00
|
| Change In Working Capital |
|
-0.23
+95.22%
|
-4.79
-11.32%
|
-4.30
-35.29%
|
-3.18
|
| Change In Receivables |
|
0.00
-100.00%
|
0.93
+150.81%
|
0.37
+130.06%
|
-1.23
|
| Changes In Account Receivables |
|
0.00
-100.00%
|
0.93
+150.81%
|
0.37
+130.06%
|
-1.23
|
| Change In Prepaid Assets |
|
0.36
+4.37%
|
0.34
+5.21%
|
0.33
+265.48%
|
-0.20
|
| Change In Payables And Accrued Expense |
|
-0.60
+61.14%
|
-1.54
-337.39%
|
-0.35
-138.54%
|
0.92
|
| Change In Accrued Expense |
|
-0.06
+85.62%
|
-0.44
+59.44%
|
-1.08
-366.67%
|
0.41
|
| Change In Payable |
|
-0.54
+51.45%
|
-1.11
-252.13%
|
0.73
+42.27%
|
0.51
|
| Change In Account Payable |
|
-0.54
+51.45%
|
-1.11
-252.13%
|
0.73
+42.27%
|
0.51
|
| Change In Other Working Capital |
|
—
|
-4.34
-139.26%
|
-1.82
-114.40%
|
-0.85
|
| Change In Other Current Assets |
|
0.01
-92.02%
|
0.16
-23.47%
|
0.21
+154.76%
|
-0.39
|
| Change In Other Current Liabilities |
|
0.00
+100.00%
|
-0.33
+89.05%
|
-3.04
-112.51%
|
-1.43
|
| Investing Cash Flow |
|
0.00
+100.00%
|
-0.40
+41.12%
|
-0.68
-686.05%
|
-0.09
|
| Cash Flow From Continuing Investing Activities |
|
0.00
+100.00%
|
-0.40
+41.12%
|
-0.68
-686.05%
|
-0.09
|
| Net PPE Purchase And Sale |
|
0.00
+100.00%
|
-0.40
+41.12%
|
-0.68
-686.05%
|
-0.09
|
| Purchase Of PPE |
|
0.00
+100.00%
|
-0.40
+41.12%
|
-0.68
-686.05%
|
-0.09
|
| Capital Expenditure |
|
—
|
-0.40
+41.12%
|
-0.68
-686.05%
|
-0.09
|
| Financing Cash Flow |
|
—
|
0.00
-100.00%
|
0.05
-95.69%
|
1.23
|
| Cash Flow From Continuing Financing Activities |
|
—
|
0.00
-100.00%
|
0.05
-95.69%
|
1.23
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
—
|
—
|
| Issuance Of Debt |
|
—
|
—
|
—
|
—
|
| Repayment Of Debt |
|
—
|
—
|
—
|
—
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
—
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Net Common Stock Issuance |
|
—
|
0.00
-100.00%
|
0.05
-96.16%
|
1.38
|
| Repurchase Of Capital Stock |
|
—
|
—
|
—
|
-0.15
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
-0.15
|
| Changes In Cash |
|
-5.43
+51.12%
|
-11.11
+33.08%
|
-16.61
+8.81%
|
-18.21
|
| Beginning Cash Position |
|
9.53
-53.83%
|
20.64
-44.58%
|
37.25
-32.84%
|
55.47
|
| End Cash Position |
|
4.10
-57.00%
|
9.53
-53.83%
|
20.64
-44.58%
|
37.25
|
| Free Cash Flow |
|
-5.43
+51.12%
|
-11.11
+33.29%
|
-16.66
+14.30%
|
-19.44
|
| Common Stock Issuance |
|
—
|
0.00
-100.00%
|
0.05
-96.16%
|
1.38
|
| Issuance Of Capital Stock |
|
—
|
0.00
-100.00%
|
0.05
-96.16%
|
1.38
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
-0.15
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
| Preferred Stock Payments |
|
—
|
—
|
—
|
-0.15
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-21 View
- 8-K2026-03-27 View
- 8-K2026-03-02 View
- 10-K2026-02-26 View
- 8-K2026-02-26 View
- 8-K2025-12-18 View
- 10-Q2025-10-16 View
- 8-K2025-10-16 View
- 10-Q2025-08-06 View
- 8-K2025-08-06 View
- 8-K2025-06-16 View
- 10-Q2025-05-15 View
- 8-K2025-05-15 View
- 8-K2025-04-10 View
- 8-K2025-04-08 View
- 10-K2025-03-21 View
- 8-K2025-03-21 View
- 8-K2025-02-14 View
- 8-K2024-12-20 View
- 8-K2024-11-13 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|